Rankings
▼
Calendar
ARVN Q4 2020 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$907M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-54.7% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$43M
-1948.6% margin
Net Income
-$42M
-1873.4% margin
EPS (Diluted)
$-0.99
QoQ Revenue Growth
-70.8%
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$31M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$717M
Total Liabilities
$75M
Stockholders' Equity
$642M
Cash & Equivalents
$588M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$5M
-54.7%
Gross Profit
$2M
$5M
-54.7%
Operating Income
-$43M
-$23M
-89.6%
Net Income
-$42M
-$21M
-97.4%
← FY 2020
All Quarters
Q1 2021 →